(PRESS RELEASE) EXETER, 17-Dec-2021 — /EuropaWire/ — University of Exeter, a public research university in Exeter, Devon, South West England, United Kingdom, has announced that a research that it led together with Rigel Pharmaceuticals (NASDAQ: RIGL), a biotech firm dedicated … Read the full press release
Posted in Education, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AMPK, anxiety, blood sugar levels, blood sugars, brain-pancreas, coma, confusion, Conor McKeever, Diabetes, Diabetes UK, dizziness, Dr Ana Cruz, Dr Craig Beall, Dr Lucy Chambers, Endocrinology, Frontiers in Endocrinology, glucose-sensing neurons, GT1-7 cells, hormonal defence systems, Hunger, hyperglycaemia, hypoglycaemia, hypos, insulin, JDRF, loss of consciousness, low blood sugar, metformin, palpitations, R481, RESEARCH, Rigel Pharmaceuticals, sweating, University of Exeter
(PRESS RELEASE) AMSTERDAM, 14-Dec-2021 — /EuropaWire/ — Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, has announced the acquisition of Vesper Medical Inc., a US-based medical technology company that develops minimally-invasive peripheral vascular devices. The acquired … Read the full press release
Posted in Business, Healthcare, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged acquisition, advanced venous stent, Bruce Shook, Chris Landon, deep venous disease, diagnostic, health technology, Intact Vascular, intravascular ultrasound, IVUS catheters, live 2D/3D interventional imaging, medical technology, PAD, peripheral artery disease, peripheral atherectomy devices, peripheral therapy devices, peripheral vascular, peripheral vascular devices, Royal Philips, therapeutic devices, venous imaging, Vesper Medical, Vesper Medical Inc
People with moderate or mild haemophilia A have significant unmet clinical needs, as this population may not use preventative treatments due to missed or delayed diagnoses of bleeding episodes and a lack of treatment guidelines1,2 New data indicate that Hemlibra has a favourable safety profile in … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged American Society of Hematology, ASH, bleeding, blood clotting, blood disease, Chugai, Chugai Pharmaceutical, diagnostics, emicizumab, Genentech, haemophilia, Haemophilia A, HAVEN 6, Hemlibra®, Levi Garraway, pharmaceuticals, pharmacodynamics, pharmacokinetics, phase III HAVEN 6 study, prophylactic, Roche
Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to specific diseases and is helping drive personalised healthcare Preparing DNA for sequencing libraries is complex and prone to human error, which can interfere with accurate sequencing results The new AVENIO … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged advance sequencing technologies, AVENIO Edge System, diagnostic solutions, diagnostics, In Vitro Diagnostics, integrated sequencing, IVD, next-generation sequencing, NGS, Roche, sequencing library preparation, Thomas Schinecker
An innovative solution seamlessly integrates trade finance, cash management and FX needs, into a single, streamlined and automated workflow (PRESS RELEASE) FRANKFURT AM MAIN, 2-Dec-2021 — /EuropaWire/ — Deutsche Bank (ETR: DBK), Germany’s leading multinational investment bank and financial services … Read the full press release
Posted in Artificial Intelligence (AI), Banks, Financial, Germany, Investment, News, Pharma & Biotech, Technology
Tagged AI, analytics, artificial-intelligence, automation, Deutsche Bank, FX execution, FX risk, Jörg Bermüller, liquidity management, Merck India, Rajesh Thakur, Receivables Matching, regulatory validations, risk management, treasury, treasury workflow
Origimm brings expertise in antigen discovery for immune modulation of skin microbiome-associated disorders Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide Sanofi to leverage its next-generation mRNA platform to unlock … Read the full press release
Posted in Austria, Business, France, Healthcare, News, Pharma & Biotech
Tagged acne, acne vulgaris, acquisition, antigens, biotechnology, Cutibacterium acnes bacterium, microbiome, mRNA, ORI-001, Origimm Biotechnology GmbH, Sanofi, Sanya Selak, skin disease, skin immunology, skin microbiome, Thomas Triomphe, virulent skin microbiome
(PRESS RELEASE) HELSINKI, 30-Nov-2021 — /EuropaWire/ — University of Helsinki, the oldest and largest institution of academic education in Finland, and University Hospital Helsinki, Finland’s largest provider of healthcare services, have announced that their researchers have developed a method to … Read the full press release
Posted in Education, Finland, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged autologous cells, autologous pluripotent stem cells, Biomedicum Helsinki Stem Cell Center, corrected stem cells, CRISPR-Cas9, DNA errors, gene alterations, gene editing, gene scissors, genetic alterations, genetic diseases, immunological challenges, iPSCs, Joonas Sokka, Kirmo Wartiovaara, Ras Trokovic, researchers, Rocío Maldonado, Sami Jalil, skin biopsy, Stem cells, therapies, Timo Keskinen, Timo Otonkoski, University Hospital Helsinki, University of Helsinki
EQT Infrastructure has agreed to acquire Icon Group from a consortium including Goldman Sachs Asset Management, QIC and Pagoda. Goldman Sachs Asset Management will remain a minority shareholder as part of the transaction Icon Group is Australia’s largest vertically integrated cancer … Read the full press release
Posted in Business, Healthcare, Investment, Management, News, Pharma & Biotech, Science, Sweden, Technology
Tagged acquisition, Australia, Blikk, cancer care, cancer clinical trials, cancer drug infusions, cancer patients, cancer treatment, compounding, decentralisation, Deloitte, diagnostic imaging provider, digitalization, EQT, EQT Infrastructure, EQT Infrastructure V, Goldman Sachs Asset Management, healthcare sector, Herbert Smith Freehills, I-MED, Icon Group, integrated cancer-care operator, Integrated Clinical Oncology Network, investment, Jim Kelly, Ken Wong, Mark Middleton, medical oncology, Meine Radiologie Holding, Morgan Stanley, nuclear medicine, oncology, Pagoda Investment Advisors, pharmacy, PwC, QIC Private Capital Pty Ltd, Radiation Oncology, radiology, radiotherapy, Stephanie Hui
(PRESS RELEASE) HOERSHOLM, Denmark, 16-Nov-2021 — /EuropaWire/ — Chr. Hansen (CPH: CHR), a Danish bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries, has announced the latest addition to its sugar reduction portfolio for … Read the full press release
Posted in Agriculture, Denmark, Food & Beverage, News, Pharma & Biotech, Science
Tagged Chr. Hansen, cultures, dairy producers, enzymatic activity, enzymes, fermentation, fresh dairy, glucose, Ha-Lactase™, Katarzyna McCall, lactose, low-sugar, NOLA® Fit, reduce lactose, sugar reduction, SWEETY®, SWEETY® Y-3, YoFlex®, yogurt
(PRESS RELEASE) KFAR SABA, Israel, 9-Nov-2021 — /EuropaWire/ — Origami, a leading provider of no-code business process automation software for Medical Device and other industries, and citoQualis, a regulatory and business advisory leader for EU Medical Device companies, are announcing … Read the full press release
Posted in Healthcare, News, Pharma & Biotech
Tagged Amanda Brewster, business process automation, cGMP, citoQualis, EU MDR, EU regulatory, EU regulatory updates, GMP, GROWTH, ISO 13485, ISO 9001, IVDR, Life Science, Market Access, MDSAP, medical device, origami, patient safety, Pharmaceutical, QMS, Quality Management, Regulation (EU) 2017/745, Regulations, regulatory compliance, supply chain, US, Wolfgang Werner, Yaniv Shimony
Agreement sharpens AstraZeneca’s focus on priority medicines in Respiratory & Immunology portfolio (PRESS RELEASE) CAMBRIDGE, 1-Nov-2021 — /EuropaWire/ — AstraZeneca (LON: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced it sold the global rights of its chronic obstructive … Read the full press release
Posted in Business, Healthcare, Management, News, Pharma & Biotech
Tagged Aclidinium bromide, Almirall S.A., Alvesco, AstraZeneca, biopharmaceutical, Bretaris, Chronic obstructive pulmonary disease, COPD, Covis Pharma, Covis Pharma Group, Duaklir, Eklira, formoterol, Genuair, Genuair device, global rights, inhaler, LABA, LAMA, long-acting beta2-agonist, long-acting muscarinic antagonist, medicines, Omnaris, Pressair, respiratory medicines, rights, Tudorza, Zetonna
Every year, over 604,000 women worldwide are diagnosed with cervical cancer and approximately 342,000 die from this preventable disease, caused by Infection with high-risk human papillomavirus (HPV). As recently published in the International Journal of Cancer, the IMPACT (IMproving Primary screening And Colposcopy … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Switzerland, Technology
Tagged biomarker, cervical cancer, cervical cells, cervical pre-cancers, CINtec PLUS Cytology, Colposcopy Triage, HPV, HPV-positive women, human papillomavirus, impact, International Journal of Cancer, Pap cytology, Roche, testing
(PRESS RELEASE) GENEVA, 28-Oct-2021 — /EuropaWire/ — SGS, the world’s leading testing, inspection and certification company, has announced the expansion of its Glasgow biosafety testing facility thus helping to accelerate quality testing and reduce turnaround time for its clients. The … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Archie Lovatt, biological medicines, biologics, biologics manufacturers, biopharmaceutical, Biosafety Center of Excellence, BSL-2 cabinets, cell culture, cell therapies, COVID-19 vaccine, drug development, ELISA, gene therapies, Glasgow, Good Laboratory Practices, Good Manufacturing Practices, laboratories, monoclonal antibodies, polymerase chain reaction, real-time PCR testing, SGS, vaccines, virus detection
(PRESS RELEASE) ESPOO, 26-Oct-2021 — /EuropaWire/ — Gasum, a Finnish state-owned energy company responsible for the import of the nation’s natural gas, has announced that its biogas is used in the Post Nord’s biogas-powered vehicles for the transportation of medicines … Read the full press release
Posted in Environment, Finland, Industrial, Infrastructure & Utilities, News, Pharma & Biotech, Transportation & Logistics
Tagged biogas, biogas-powered vehicles, climate friendly, climate goals, Gasum biogas, health products, Ilmo Strömberg, Katja Toivonen, logistics, Markku Suopanki, medicines, NOx, pharmaceuticals, Post Nord, PostNord, SoX, Tamro
(PRESS RELEASE) BUCKINGHAMSHIRE, UK, 26-Oct-2021 — /EuropaWire/ — This year, Baltimore Innovations will be unveiling a new range of Humidity Balancing desiccants at Medica 2021. These HUMI-BALANCE™ Sachets are ideal for applications where products need to be protected not only … Read the full press release
Posted in Chemicals, Germany, Industrial, Marketing, News, Pharma & Biotech, Technology, United Kingdom
Tagged Alere, B-SURE™, Baltimore Innovations, Barrier Foil Pouches, BP, desiccants, GlaxoSmithKline, HUMI-BALANCE™ Sachets, Humidity Balancing desiccants, Matthew Valentine, Medica 2021, Medica Show, Moisture-control, OTC, pharmaceuticals, Philippe Depois, Silica Gel Sachets, SUPERDRYPAK™
New product specifically for the needs of aging skin Essential calcium improves overall skin integrity Halal-certified blend of 100% of plant and mineral origin serves sustainable market trends (PRESS RELEASE) DARMSTADT, 11-Oct-2021 — /EuropaWire/ — Merck (ETR: MRK), a German … Read the full press release
Posted in Germany, News, Pharma & Biotech, Science, Technology
Tagged cosmetic ingredient, dermocosmetics, epidermis, hydrophilic, mature skin, Merck, natural amino acids, Natural Moisturizing Factor, natural skin aging, RonaCare® Epintegrity, skin, skin care, Skin cells, skin hydration, Wiebke Dondras
(PRESS RELEASE) CAMBRIDGE, 29-Sep-2021 — /EuropaWire/ — AstraZeneca (LON: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced its rare diseases arm Alexion has exercised its option to acquire all remaining equity in Caelum Biosciences, Inc., a Clinical Stage … Read the full press release
Posted in Business, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged abnormal antibody, acquisition, AL amyloidosis, Alexion, amyloids, AstraZeneca, bone marrow, CAEL-101, Caelum Biosciences, Cardiac Amyloid Reaching for Extended Survival, CARES Phase III clinical programme, defective plasma cells, IIIb disease, immunoglobulin, light chain (AL) amyloidosis, mAb, Marc Dunoyer, Mayo stage IIIa, monoclonal antibody, rare disease
EASD 2021 – Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, is presenting new real-world data(1) of its Automated Insulin Delivery system, DBLG1. The personalized device fine-tunes insulin delivery using a state-of-the-art algorithm. Thousands of European patients have … Read the full press release
Posted in Artificial Intelligence (AI), France, Healthcare, Italy, News, Pharma & Biotech, Science, Spain, Technology
Tagged ACCU-CHEK, Accu-Chek Insight, algorithm, artificial-intelligence, Automated Insulin Delivery system, CE certificate, CGM, continuous glucose monitor, data, data visualization platform, DBLG1, DBLG1 System, Dexcom, Dexcom G6, Diabeloop, Diabetes, EASD 2021, Erik Huneker, glucose, HbA1c, Hypoglycemia, Insulin Pump, Pr. Pierre-Yves Benhamou, Roche, Stéphanie JEGU, T1D, therapeutic artificial intelligence, therapeutic artificial intelligence for diabetes management, Time In Range, TÜV Rheinland, type 1 diabetes, YourLoops
(PRESS RELEASE) CAMBRIDGE, 24-Sep-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical and biopharmaceutical company, has announced positive high-level results from the PROpel Phase III trial showed AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone demonstrated a … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged abiraterone, AstraZeneca, Cancer, chemotherapy, Eastern Cooperative Oncology Group, EcoG, hormones, HRR, IDMC, Independent Data Monitoring Committee, Lynparza, mCRPC, MSD, MSD Research Laboratories, Olaparib, PARP, PROpel Phase III, prostate cancer, Roy Baynes, rPFS, Susan Galbraith
New data show pre-symptomatic babies with spinal muscular atrophy (SMA) treated with Evrysdi maintained the ability to swallow Evrysdi has demonstrated consistent clinically meaningful efficacy in adults, children, and babies two months and older and is now approved in 58 countries worldwide Further … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged DMD, Duchenne muscular dystrophy, Endeavor, Evrysdi, gene therapy, Hammersmith Infant Neurological Examination, HINE-2, Levi Garraway, M.D. Ph.D, motor milestones, neuromuscular, RAINBOWFISH study, risdiplam, Roche, Sarepta, SMA, spinal muscular atrophy, SRP-9001, World Muscle Society (WMS) Virtual Congress
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?